Charles Schwab Investment Management Inc Capricor Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,479 shares of CAPR stock, worth $64,294. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,479
Previous 13,479
-0.0%
Holding current value
$64,294
Previous $65,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CAPR
# of Institutions
62Shares Held
4.74MCall Options Held
123KPut Options Held
53.8K-
Vanguard Group Inc Valley Forge, PA1.37MShares$6.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY382KShares$1.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA328KShares$1.57 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA316KShares$1.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny293KShares$1.4 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $116M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...